FDA Asks Congress To Reform The Drug Accelerated Approval Pathway

By Beth Wang / March 29, 2022 at 12:28 PM

FDA on Monday (March 28) proposed legislative reforms that would give the agency additional authority over accelerated approval drugs, offering a potential middle ground as lawmakers debate competing ways to beef up the controversial accelerated approval pathway.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.